Treatment may be offered to hundreds with severe form of disease, most often found in people of Mediterranean, Asian and Middle Eastern heritage
People living with a rare genetic blood disorder in England will be offered a “life-changing” new treatment on the NHS, in what has been described as a historic moment.
Casgevy, which is a one-off gene therapy, has been approved for use on the NHS in England for people living with a severe form of thalassaemia.
More Stories
Elon Musk shows he still has the White House’s ear on Trump’s Middle East trip
Australians may soon be able to download iPhone apps from outside Apple App Store under federal proposal
The Guardian view on the Trump-Musk feud: we can’t rely on outsized egos to end oligopoly | Editorial